Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

The Trump administration’s negotiation with Novo Nordisk A/S that slashes 71% off the list price of its blockbusters Ozempic ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, Novo Nordisk said.

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have ...

The origins: Opened in 1958 by a Holocaust survivor as an aerospace liquidation business and surplus store, the Sun Valley ...

Novo Nordisk stock jumped Wednesday on a lighter-than-feared discount for Ozempic and Wegovy under the Inflation Reduction ...

Medicare has negotiated steep new prices for 15 high-cost drugs, including Novo Nordisk’s blockbuster semaglutide (Wegovy and Ozempic), with negotiated prices set to take effect in 2027. The move cuts ...

Medicare will save approximately 44%, on 15 high-cost medications as a result of the second round of the program’s drug price ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round ...